Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors

被引：12
|
作者：
Firooznia, F [1 ]
Gude, C [1 ]
Chan, K [1 ]
Fink, CA [1 ]
Qiao, Y [1 ]
Satoh, Y [1 ]
Marcopoulos, N [1 ]
Savage, P [1 ]
Beil, ME [1 ]
Bruseo, CW [1 ]
Trapani, AJ [1 ]
Jeng, AY [1 ]
机构：
[1] Novartis Inst Biomed Res, Summit, NJ 07901 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 03期
关键词：
D O I：
10.1016/S0960-894X(00)00657-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Through directed screening of metalloprotease inhibitors. CGS 30084 (1) has been identified as a potent endothelin-converting enzyme-1 (ECE-1) inhibitor in vitro (IC50 = 77 nM). Herein we report the synthesis and biological activities of analogues derived from this lead. based on modifications of the biphenyl moiety. Compound 10. the thioacetate methyl ester prodrug derivative of compound 6m. was found to he an orally active and potent inhibitor of ECE-1 activity in rats. (C) 2001 Elsevier science Ltd. All rights reserved.
引用
收藏
页码：375 / 378
页数：4
相关论文
共 50 条
  • [1] Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1
    Firooznia, F
    Gude, C
    Chan, K
    Tan, J
    Fink, CA
    Savage, P
    Beil, ME
    Bruseo, CW
    Trapani, AJ
    Jeng, AY
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3059 - 3062
  • [2] Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1
    Takayanagi, R
    Liu, W
    Ito, T
    Ohnaka, K
    Nawata, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S62 - S63
  • [3] Endothelin-converting enzyme-1 in cancer aggressiveness
    Tapia, Julio C.
    Niechi, Ignacio
    CANCER LETTERS, 2019, 452 : 152 - 157
  • [4] Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme
    Wallace, EM
    Moliterni, JA
    Moskal, MA
    Neubert, AD
    Marcopulos, N
    Stamford, LB
    Trapani, AJ
    Savage, P
    Chou, M
    Jeng, AY
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (09) : 1513 - 1523
  • [5] Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action
    De Lombaert, S
    Blanchard, L
    Stamford, LB
    Tan, J
    Wallace, EM
    Satoh, Y
    Fitt, J
    Hoyer, D
    Simonsbergen, D
    Moliterni, J
    Marcopoulos, N
    Savage, P
    Chou, M
    Trapani, AJ
    Jeng, AY
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (03) : 488 - 504
  • [6] PURIFICATION AND CHARACTERIZATION OF RECOMBINANT ENDOTHELIN-CONVERTING ENZYME-1
    EMOTO, N
    TAKEDA, S
    YANAGISAWA, M
    CIRCULATION, 1995, 92 (08) : 3043 - 3043
  • [7] Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1
    Fink, CA
    Moskal, M
    Firooznia, F
    Hoyer, D
    Symonsbergen, D
    Wei, DC
    Qiao, Y
    Savage, P
    Beil, ME
    Trapani, AJ
    Jeng, AY
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (17) : 2037 - 2039
  • [8] Placental endothelin-converting enzyme-1 is decreased in preeclampsia
    McCormick, Anna
    Kristianto, Jasmin
    Wang, Xiaohu
    McIntosh, Jennifer
    Cruz, Meredith
    Hibbard, Judith U.
    Blank, Robert D.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2020, 20 : 108 - 110
  • [9] Localization of endothelin-converting enzyme-1 in human kidney
    Pupilli, C
    Romagnani, P
    Lasagni, L
    Bellini, F
    Misciglia, N
    Emoto, N
    Yanagisawa, M
    Rizzo, M
    Mannelli, M
    Serio, M
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (05) : F749 - F756
  • [10] Functional significance of the isoforms of endothelin-converting enzyme-1
    Brown, CD
    Barnes, K
    Turner, AJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S26 - S27
12345